Health Care & Life Sciences » Pharmaceuticals | Fuji Pharmaceutical Co. Ltd.

Fuji Pharmaceutical Co. Ltd. | Ownership

Companies that own Fuji Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Management & Research Co.
786,600
2.52%
-21,800
0%
07/31/2018
Rheos Capital Works, Inc.
379,600
1.22%
-32,600
0.11%
10/02/2017
The Vanguard Group, Inc.
328,000
1.05%
0
0%
07/31/2018
Nomura Asset Management Co., Ltd.
319,698
1.02%
93,200
0%
07/31/2018
Norges Bank Investment Management
308,600
0.99%
184,000
0%
12/31/2017
Dimensional Fund Advisors LP
191,600
0.61%
7,800
0%
04/30/2018
Daiwa Asset Management Co. Ltd.
111,898
0.36%
-3,302
0%
07/31/2018
Nikko Asset Management Co., Ltd.
100,798
0.32%
-71,402
0%
08/20/2018
T&D Asset Management Co., Ltd.
99,694
0.32%
-119,906
0.07%
04/25/2017
Russell Investments Japan Co. Ltd.
66,800
0.21%
37,400
0.22%
03/31/2018

About Fuji Pharmaceutical Co.

View Profile
Address
Seito Kaikan, 6/F
Tokyo Tokyo 102
Japan
Employees -
Website http://www.fujipharma.jp
Updated 07/08/2019
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its services include medical care for women in vitro diagnostics, sale of acute medical care products and curative medicine (injection agents), and provides information regarding pharmaceuticals and healthcare. The company products include injection agents, internal drugs, drugs for external use, diagnostic agent, hormonal agent, cardiovascular preparation, antibiotic drugs, chemotherapeutic agent, genitourinary related drugs, dermatological preparation and others.